| Ashita Tolwani, MD Birmingham, AL USA Dr. Ashita Tolwani is Professor of Medicine at the University of Alabama at Birmingham (UAB) and holder of the Edwin A. Rutsky Endowed Chair in Nephrology. She holds a Master’s of Science in Clinical Epidemiology from the Harvard School of Public Health. She is Co-Director of Section of Critical Care Nephrology at UAB. Dr. Tolwani is the founder and Director of UAB Continuous Renal Replacement Therapy (CRRT) Academy where she oversees every aspect of the program including development, organization and implementation of the curriculum. She also conducts CRRT training workshops internationally. Her dedication and quality has resulted in her receiving numerous institutional teaching awards. In 2020, she was honored with the American Society of Nephrology (ASN), Robert G. Narins Award (Lifetime Teaching Award in Education). Her research interests include acute kidney injury, ICU nephrology, and CRRT, with a focus on citrate anticoagulation. She holds the patent for 0.5% Citrate solution for CRRT which is available worldwide as Regiocit or Prismocitrate 18/0.
|